Comparing the current results to its competitors, Infusystem Holdings Inc reported Revenue increase in the 2 quarter 2026 by 2.59 % year on year. The revenue growth was below Infusystem Holdings Inc's competitors' average revenue growth of 6.68 %, achieved in the same quarter.
Infusystem Holdings Inc Net Income in the 2 quarter 2026 grew year on year by 24.32%, faster than the Infusystem Holdings Inc's competitors average income growth of 8.94 %
Avanos Medical Inc's business model focuses on the development, manufacturing, and distribution of medical devices and technology solutions for various healthcare applications.
Henry Schein Inc operates as a global distributor of healthcare products, services, and technology solutions, primarily targeting dental and medical professionals. Their business model emphasizes a vast network of sales consultants and a diverse product range from various manufacturers, aiming to deliver high-quality products, innovative solutions, and exceptional customer service to enhance patient care and improve practice efficiency.
Cardinal Health Inc operates as a prominent integrated healthcare services provider in the United States, specializing in the distribution of pharmaceuticals and medical products to various healthcare settings, including retail pharmacies and hospitals. The company enhances healthcare efficiency through a range of services such as inventory management, medication therapy management, and data analytics solutions aimed at optimizing operations and improving patient care.
Herbalife Nutrition Ltd operates as a multi-level marketing company that focuses on the manufacturing and distribution of nutritional supplements, weight management products, and personal care items. The company sells its products through a network of independent distributors who earn commissions based on their sales volume and the sales volume of their downline recruits. Herbalife primarily generates revenue from product sales and recruitment activities within its distributor network.
McKesson Corporations business model centers on healthcare distribution and technology solutions, supplying pharmaceuticals, medical supplies, and business services to pharmacies, hospitals, and healthcare providers. They emphasize efficiency and innovation in healthcare delivery.
Sources:
Infusystem Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Infusystem Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
